REVELATION BIOSCIENCES, INC.（REVB）内部人交易：高管与董事近期交易
过去 18 个月，共有 5 位内部人为 REVELATION BIOSCIENCES, INC.（REVB）报告了 24 笔 Form 4 交易（最近一笔 2026-08-18）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-18 | ROPER JESS | 董事 | 买入 | 32,011 | $0 |
| 2026-08-18 | Chawla Lakhmir S | 董事 | 买入 | 32,011 | $0 |
| 2026-08-18 | CARVER JENNIFER | 董事 | 买入 | 32,011 | $0 |
| 2026-08-18 | Rolke James | Chief Executive Officer | 买入 | 208,076 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | 买入 | 208,073 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | 卖出 | 208,073 | $0 |
| 2026-08-18 | Zygmont Chester Stanley III | Chief Financial Officer | 买入 | 208,073 | $0 |
| 2026-05-01 | Zygmont Chester Stanley III | Chief Financial Officer | 卖出 | 13,285 | $14,614 |
| 2026-05-01 | Rolke James | Chief Executive Officer | 卖出 | 10,115 | $11,430 |
| 2026-02-05 | CARVER JENNIFER | 董事 | 卖出 | 1,661 | $3,106 |
| 2026-02-05 | ROPER JESS | 董事 | 卖出 | 1,591 | $2,943 |
| 2026-02-05 | Chawla Lakhmir S | 董事 | 卖出 | 2,261 | $4,183 |
| 2026-02-05 | Zygmont Chester Stanley III | Chief Financial Officer | 卖出 | 13,100 | $21,615 |
| 2026-02-05 | Rolke James | Chief Executive Officer | 卖出 | 8,521 | $15,849 |
| 2026-01-12 | Zygmont Chester Stanley III | Chief Financial Officer | 买入 | 78,145 | $70,330 |
| 2026-01-12 | Rolke James | Chief Executive Officer | 买入 | 532,829 | $479,546 |
| 2026-01-12 | Chawla Lakhmir S | 董事 | 买入 | 41,981 | $37,783 |
| 2026-01-12 | CARVER JENNIFER | 董事 | 买入 | 41,981 | $37,783 |
| 2026-01-12 | ROPER JESS | 董事 | 买入 | 41,981 | $37,783 |
| 2025-10-31 | Chawla Lakhmir S | 董事 | 买入 | 15,625 | $20,000 |
| 2025-10-31 | CARVER JENNIFER | 董事 | 买入 | 15,625 | $20,000 |
| 2025-10-31 | Zygmont Chester Stanley III | Chief Financial Officer | 买入 | 390,614 | $499,986 |
| 2025-10-31 | ROPER JESS | 董事 | 买入 | 15,625 | $20,000 |
| 2025-10-31 | Rolke James | Chief Executive Officer | 买入 | 390,614 | $499,986 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18